Servier

190 articles about Servier

• XOMA Corporation Announces Servier Has Initiated a Proof-of-Concept Gevokizumab Study in Patients With a History of Acute Coronary Syndrome

  11/29/2012

• Florey Neurosciences Institutes and Servier to Collaborate on a Novel Target for Alzheimer's Disease

  10/15/2012

• NovAliX and Servier Collaborate in Early Discovery Research Program

  10/9/2012

• Servier Concludes a Collaboration and License Agreement With EOS for Its Antitumor Drug E-3810

  10/1/2012

• XOMA (US) LLC Announces Servier Has Initiated Phase 3 Gevokizumab Trial in Patients With Behcet's Uveitis

  9/27/2012

• Vernalis PLC and Servier Achieve Research Milestone in First Oncology Collaboration

  9/20/2012

• MacroGenics, Inc. Could Earn More Than $1 Billion Through New Servier Alliance

  9/20/2012

• EU Antitrust Charge for Servier, Teva Pharmaceutical Industries Limited, Others Over Generics

  7/31/2012

• Galapagos NV Delivers Candidate Drug in Osteoarthritis Alliance With Servier

  7/24/2012

• Servier Trial In France Delayed Over Appeal

  5/22/2012

• Servier on Trial Over Diabetes-Diet Pill

  5/14/2012

• Vernalis PLC and Servier Achieve Research Milestone in Drug Discovery Collaboration

  4/25/2012

• Servier's Protelos Effective Against Weak Bones

  3/26/2012

• Galapagos NV Receives EUR3.5 Million in Milestones in Osteoarthritis Alliance With Servier

  3/2/2012

• Servier Mediator Investigation Continues With Afssaps, Home Searches

  2/3/2012

• Antitrust: Commission Closes Procedural Case Against Servier

  1/30/2012

• BioInvent and Servier Enter Oncology Collaboration

  1/4/2012

• Galapagos NV Receives EUR4 Million in Milestones From Servier in Their Osteoarthritis Alliance

  12/15/2011

• MacroGenics, Inc. Inks Pharma Deal With Servier Worth Up to $450 Million

  12/1/2011

• Servier Enters Into a Type 2 Diabetes Partnership with Canadian Firm Prognomix Inc.

  11/8/2011